|
🐜
|
Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study.
7 auth.
L. Staals,
M. Snoeck,
J. Driessen,
H. V. Hamersvelt,
E. Flockton,
M. D. Heuvel,
...
J. Hunter
|
7 |
2010 |
7
🐜
|
|
🐜
|
The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study.
12 auth.
P. Schneeberger,
I. Keur,
A. M. Loon,
D. Mortier,
Katja Op de Coul,
A. V. Haperen,
...
Ricardo Sanna,
T. V. D. Heijden,
Heidi van den Hoven,
H. V. Hamersvelt,
W. Quint,
L. V. Doorn
|
6 |
2000 |
6
🐜
|
|
🐜
|
Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole.
8 auth.
F. Bosma,
A. Voss,
H. V. Hamersvelt,
R. D. Sévaux,
J. Biert,
B. Kullberg,
...
W. Melchers,
P. Verweij
|
5 |
2003 |
5
🐜
|
|
🐜
|
Survival on renal replacement therapy in Europe: is there a ‘centre effect’?
18 auth.
I. Khan,
M. Campbell,
D. Cantarovich,
G. Catto,
C. Delcroix,
N. Edward,
C. Fontenaille,
L. Fleming,
P. Gerlag,
H. V. Hamersvelt,
...
I. Henderson,
R. Koene,
M. Papadimitriou,
E. Ritz,
I. Russell,
E. Stier,
D. Tsakiris,
A. Macleod
|
4 |
1996 |
4
🐜
|
|
🐜
|
Placental disposition of the immunosuppressive drug tacrolimus in renal transplant recipients and in ex vivo perfused placental tissue
9 auth.
J. Freriksen,
D. Feyaerts,
P. V. D. Broek,
O. V. D. Heijden,
J. Drongelen,
H. V. Hamersvelt,
...
F. Russel,
R. G. van der Molen,
R. Greupink
|
4 |
2018 |
4
🐜
|
|
🐜
|
Cytokine profiles in BAL and blood in HIV-seronegative patients with Pneumocystis carinii pneumonia
8 auth.
R. Perenboom,
J. Schijndel,
P. Beckers,
R. Sauerwein,
H. V. Hamersvelt,
J. Festen,
...
H. Gallati,
J. V. D. Meer
|
4 |
1996 |
4
🐜
|
|
🐬
|
Pharmacokinetics and haemodynamic effects of the angiotensin converting enzyme inhibitor cilazapril in hypertensive patients with normal and impaired renal function.
H. Kloke,
R. J. Ambros,
H. V. Hamersvelt,
J. Wetzels,
R. -,
F. Huysmans
|
2 |
1996 |
2
🐬
|
|
🦁
|
Brains and bones.
H. V. Hamersvelt
|
1 |
1998 |
1
🦁
|
